BiotechTube
Home/Pipeline/CTLA-4/B7-1 Inhibitor Screening Kit

CTLA-4/B7-1 Inhibitor Screening Kit

Immuno-oncology

CommercialAvailable

Key Facts

Indication
Immuno-oncology
Phase
Commercial
Status
Available
Company
Aurora Biolabs

About Aurora Biolabs

Aurora Biolabs operates as a premier manufacturer and service provider in the life sciences research tools sector, focusing on enabling drug discovery through reliable, ISO 17025-certified reagents and assays. As a subsidiary of Structure Based Design, Inc. (SBD), it leverages decades of scientific expertise to offer assay development, protein expression, and a 145K-compound library screening service. The company is strategically positioned as a direct US manufacturer, ensuring quality control and cost-effective solutions for academic, biotech, and pharmaceutical research clients.

View full company profile

Therapeutic Areas

OncologyInfectious DiseaseImmunology

Other Immuno-oncology Drugs

DrugCompanyPhase
PD-1/PD-L1 Inhibitor Binding Assay KitAurora BiolabsCommercial
OX40 & PD-1 AssayAurora BiolabsCommercial
HPK1 inhibitorAcelleraPre-clinical
SKP2-CKS1 PPI InhibitorIktosHit-to-Lead
PD-1 Expression InhibitorBCN BiosciencesPreclinical
CCR8 ADCIntegral MolecularPreclinical
KB16AKBioDiscovery
NeoSight Neoantigen DetectionReproCELLResearch/Clinical
EMUNKITUG (HFB200301)HiFiBiO TherapeuticsPhase 1
HFB200603HiFiBiO TherapeuticsPhase 1
Undisclosed Multispecific TherapeuticsModeX TherapeuticsPre-clinical
UndisclosedOnco3R TherapeuticsPreclinical